Daniela Leronni

Dr. Daniela Leronni

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YSYalikun Suofu
Yalikun Suofu
WLWei Li
Wei Li
FJFrederic Jean-Alphonse
Frederic Jean-Alphonse
JJJiaoying Jia
Jiaoying Jia
NKNicolas K Khattar
Nicolas K Khattar
RFRobert M. Friedlander
Robert M. Friedlander
Significance: This paper describes the finding that mitochondria synthesize and release melatonin and have their selective G protein-coupled receptor (GPCR) in the outer membrane. We further demonstrate that mitochondrial melatonin type 1 receptors respond to melatonin by activating heterotrimeric G proteins located in the intermembrane space and inhibit stress-mediated cytochrome c release. This remarkable insight changes our classical understanding of biological GPCR function by showing that a cellular organelle both synthesizes and has a signaling receptor for a specific ligand. Implicit with our original work is the existence of an automitocrine signaling pathway by which melatonin prevents neurodegeneration associated with mitochondrial cytochromecrelease and downstream caspase activation.

29 July 2013 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
KLKonstantinos Lefkimmiatis
Konstantinos Lefkimmiatis
DLDaniela Leronni
Daniela Leronni
AHAldebaran M. Hofer
Aldebaran M. Hofer
Cyclic AMP (cAMP)-dependent phosphorylation has been reported to exert biological effects in both the mitochondrial matrix and outer mitochondrial membrane (OMM). However, the kinetics, targets, and effectors of the cAMP cascade in these organellar domains remain largely undefined. Here we used sensitive FRET-based sensors to monitor cAMP and protein kinase A (PKA) activity in different mitochondrial compartments in real time. We found that cytosolic cAMP did not enter the matrix, except during mitochondrial permeability transition. Bicarbonate treatment (expected to activate matrix-bound soluble adenylyl cyclase) increased intramitochondrial cAMP, but along with membrane-permeant cAMP analogues, failed to induce measureable matrix PKA activity. In contrast, the OMM proved to be a domain of exceptionally persistent cAMP-dependent PKA activity. Although cAMP signaling events measured on the OMM mirrored those of the cytosol, PKA phosphorylation at the OMM endured longer as a consequence of diminished control by local phosphatases. Our findings demonstrate that mitochondria host segregated cAMP cascades with distinct functional and kinetic signatures.

1 December 2019 in Molecular Therapy-Oncolytics
Verified
Journal Article
Open access
PSPaola Sette
Paola Sette
NANduka Amankulor
Nduka Amankulor
ALAofei Li
Aofei Li
MMMarco Marzulli
Marco Marzulli
DLDaniela Leronni
Daniela Leronni
PGPaola Grandi
Paola Grandi
The use of mutant strains of oncolytic herpes simplex virus (oHSV) in early-phase human clinical trials for the treatment of glioblastoma multiforme (GBM) has proven safe, but limited efficacy suggests that more potent vector designs are required for effective GBM therapy. Inadequate vector performance may derive from poor intratumoral vector replication and limited spread to uninfected cells. Vector replication may be impaired by mutagenesis strategies to achieve vector safety, and intratumoral virus spread may be hampered by vector entrapment in the tumor-specific extracellular matrix (ECM) that in GBM is composed primarily of type IV collagen. In this report, we armed our previously described epidermal growth factor receptor (EGFR)vIII-targeted, neuronal microRNA-sensitive oHSV with a matrix metalloproteinase (MMP9) to improve intratumoral vector distribution. We show that vector-expressed MMP9 enhanced therapeutic efficacy and long-term animal survival in a GBM xenograft model.

24 February 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRené Marsano
René Marsano
DLDaniela Leronni
Daniela Leronni
Pietro D'AddabboPietro D'Addabbo
Pietro D'Addabbo
LVLuigi Viggiano
Luigi Viggiano
Eustachio TarascoEustachio Tarasco
Eustachio Tarasco
RCRuggiero Caizzi
Ruggiero Caizzi
A set of 67 novel LTR-retrotransposon has been identified by in silico analyses of the Culex quinquefasciatus genome using the LTR_STRUC program. The phylogenetic analysis shows that 29 novel and putatively functional LTR-retrotransposons detected belong to the Ty3/gypsy group. Our results demonstrate that, by considering only families containing potentially autonomous LTR-retrotransposons, they account for about 1% of the genome of C. quinquefasciatus. In previous studies it has been estimated that 29% of the genome of C. quinquefasciatus is occupied by mobile genetic elements. The potential role of retrotransposon insertions strictly associated with host genes is described and discussed along with the possible origin of a retrotransposon with peculiar Primer Binding Site region. Finally, we report the presence of a group of 38 retrotransposons, carrying tandem repeated sequences but lacking coding potential, and apparently lacking “master copy” elements from which they could have originated. The features of the repetitive sequences found in these non-autonomous LTR retrotransposons are described, and their possible role discussed. These results integrate the existing data on the genomics of an important virus-borne disease vector.

Verified
Journal Article
Open access
PDF file
BHBonnie Hall
Bonnie Hall
DLDaniela Leronni
Daniela Leronni
YMYoshitaka Miyagawa
Yoshitaka Miyagawa
WGWilliam F. Goins
William F. Goins
JGJoseph Charles Glorioso
Joseph Charles Glorioso
JCJustus Cohen
Justus Cohen
Oncolytic herpes simplex viruses (oHSV) are under development for the treatment of a variety of human cancers, including breast cancer, a leading cause of cancer mortality among women worldwide. Here we report the design of a fully retargeted oHSV for preferential infection of breast cancer cells through virus recognition of GFRα1, the cellular receptor for glial cell-derived neurotrophic factor (GDNF). GFRα1 displays a limited expression profile in normal adult tissue, but is upregulated in a subset of breast cancers. We generated a recombinant HSV expressing a completely retargeted glycoprotein D (gD), the viral attachment/entry protein, that incorporates pre-pro-GDNF in place of the signal peptide and HVEM binding domain of gD and contains a deletion of amino acid 38 to eliminate nectin-1 binding. We show that GFRα1 is necessary and sufficient for infection by the purified recombinant virus. Moreover, this virus enters and spreads in GFRα1-positive breast cancer cells in vitro and caused tumor regression upon intratumoral injection in vivo. Given the heterogeneity observed between and within individual breast cancers at the molecular level, these results expand our ability to deliver oHSV to specific tumors and suggest opportunities to enhance drug or viral treatments aimed at other receptors.

3 April 2010 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
Crescenzio MinerviniCrescenzio Minervini
Crescenzio Minervini
SRSimona Ruggieri
Simona Ruggieri
MTMichele Traversa
Michele Traversa
LDLeonardo A D'Aiuto
Leonardo A D'Aiuto
RMRené Marsano
René Marsano
LVLuigi Viggiano
Luigi Viggiano